EP0309827A1 — L-Dopa derivatives or their acid addition salts, process for producing same and their use
Assigned to MSD KK · Expires 1989-04-05 · 37y expired
What this patent protects
An L-dopa derivative represented by formula [I] wherein one of R 1 and R 2 denotes a hydrogen atom and the other denotes a group of formula R-CO- in which R denotes an alkyl, alkenyl, optionally substituted cycloalkyl, optionally substituted phenyl, optionally substitut…
USPTO Abstract
An L-dopa derivative represented by formula [I] wherein one of R 1 and R 2 denotes a hydrogen atom and the other denotes a group of formula R-CO- in which R denotes an alkyl, alkenyl, optionally substituted cycloalkyl, optionally substituted phenyl, optionally substituted aralkyl, lower alkoxy or optionally substituted aralkyloxy group, and its acid addition salt. The compounds are useful in the medical field, especially in the treatment of a series of diseases called Parkinson's disease or Parkinsonism.
Drugs covered by this patent
- foscarbidopa (FOSCARBIDOPA) · AbbVie GK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.